Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smyth

Showing results (171-180 of 294) with videos related to

Pageof 30
Sort By:
European Journal of Cancer & Clinical Oncology|December 1, 1982
A multicentre phase II trial of vindesine in malignant melanomaJ Carmichael, R J Atkinson, K C Calman, et al.
BMJ (Clinical Research Ed.)|August 13, 1994
Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer ResearchJ F Smyth, J Mossman, R Hall, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2005
The mechanism of action of Kahalalide F: variable cell permeability in human hepatoma cell linesJ M Sewell, I Mayer, S P Langdon, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1991
A 10-year experience of tamoxifen as primary treatment of breast cancer in 100 elderly and frail patientsS S Akhtar, S G Allan, A Rodger, et al.
Peptides|January 1, 1997
Processing of [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P in xenograft bearing Nu/Nu miceD A Jones, A J MacLellan, J Cummings, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase II trial of mitomycin C and 5-fluorouracil as second-line therapy in advanced breast cancerM E O'Brien, E J Bayliss, M E Stewart, et al.
Molecular Cancer Therapeutics|February 27, 2004
Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effectRichard L Hayward, Janet S Macpherson, Jeff Cummings, et al.
Journal of Clinical Pharmacy and Therapeutics|February 1, 1990
A pharmacokinetic study of high-dose metoclopramide suppositoriesF Hardy, P S Warrington, J S MacPherson, et al.
Cancer Chemotherapy and Pharmacology|April 6, 2002
Factors influencing the cellular accumulation of SN-38 and camptothecinJeffrey Cummings, Gary Boyd, Janet S Macpherson, et al.
British Journal of Cancer|September 1, 1992
12-O-tetradecanoylphorbol 13-acetate induced differentiation in human lung squamous carcinoma cellsG J Rabiasz, S P Langdon, L Anderson, et al.
Pageof 30

Showing results (171-180 of 294) with videos related to

Sort By:
Pageof 30
European Journal of Cancer & Clinical Oncology|December 1, 1982
A multicentre phase II trial of vindesine in malignant melanomaJ Carmichael, R J Atkinson, K C Calman, et al.
BMJ (Clinical Research Ed.)|August 13, 1994
Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer ResearchJ F Smyth, J Mossman, R Hall, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2005
The mechanism of action of Kahalalide F: variable cell permeability in human hepatoma cell linesJ M Sewell, I Mayer, S P Langdon, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1991
A 10-year experience of tamoxifen as primary treatment of breast cancer in 100 elderly and frail patientsS S Akhtar, S G Allan, A Rodger, et al.
Peptides|January 1, 1997
Processing of [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P in xenograft bearing Nu/Nu miceD A Jones, A J MacLellan, J Cummings, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase II trial of mitomycin C and 5-fluorouracil as second-line therapy in advanced breast cancerM E O'Brien, E J Bayliss, M E Stewart, et al.
Molecular Cancer Therapeutics|February 27, 2004
Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effectRichard L Hayward, Janet S Macpherson, Jeff Cummings, et al.
Journal of Clinical Pharmacy and Therapeutics|February 1, 1990
A pharmacokinetic study of high-dose metoclopramide suppositoriesF Hardy, P S Warrington, J S MacPherson, et al.
Cancer Chemotherapy and Pharmacology|April 6, 2002
Factors influencing the cellular accumulation of SN-38 and camptothecinJeffrey Cummings, Gary Boyd, Janet S Macpherson, et al.
British Journal of Cancer|September 1, 1992
12-O-tetradecanoylphorbol 13-acetate induced differentiation in human lung squamous carcinoma cellsG J Rabiasz, S P Langdon, L Anderson, et al.
Pageof 30